BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11350534)

  • 1. Bioequivalence of allopurinol and its metabolite oxipurinol in two tablet formulations.
    Guerra P; Frias J; Ruiz B; Soto A; Carcas A; Govantes C; Montuenga C; Fernández A
    J Clin Pharm Ther; 2001 Apr; 26(2):113-9. PubMed ID: 11350534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The bioequivalence of a new allopurinol tablet formulation in comparison to a reference formulation].
    Metzner JE; Buchberger D; Läuter J; Pech R
    Arzneimittelforschung; 1997 Nov; 47(11):1236-41. PubMed ID: 9463301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteers.
    Galicia I; Frias-Iniesta J; Carcas AJ; Soto A; Gomez E; Miranda E; Fernandez A; Montuenga C
    Int J Clin Pharmacol Ther; 1998 May; 36(5):282-5. PubMed ID: 9629993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence of allopurinol-containing tablet preparations.
    Barthel W; Hüller G; Haustein KO
    Int J Clin Pharmacol Ther; 1999 Mar; 37(3):148-52. PubMed ID: 10190763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals.
    Walter-Sack I; de Vries JX; Kutschker C; Ittensohn A; Voss A
    Eur J Clin Pharmacol; 1995; 49(3):215-20. PubMed ID: 8665998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence of allopurinol preparations: to be assessed by the parent drug or the active metabolite?
    Walter-Sack I; de Vries JX; Kreiner C; Ittensohn A; Stenzhorn G; Voss A; Weber E
    Clin Investig; 1993 Mar; 71(3):240-6. PubMed ID: 8481628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics or oral and intravenous allopurinol and intravenous oxypurinol in the horse.
    Mills PC; Dunnett M; Smith NC
    J Vet Pharmacol Ther; 1995 Dec; 18(6):451-6. PubMed ID: 8789699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of two diets on pharmacokinetic parameters of allopurinol and oxypurinol in healthy beagles.
    Bartges JW; Osborne CA; Felice LJ; Koehler LA; Ulrich LK; Bird KA; Chen M
    Am J Vet Res; 1997 May; 58(5):511-5. PubMed ID: 9140560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
    Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q
    Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and pharmacokinetics of intravenously and orally administered allopurinol in healthy beagles.
    Bartges JW; Osborne CA; Felice LJ; Koehler LA; Ulrich LK; Bird KA; Chen M; Sawchuk RJ
    Am J Vet Res; 1997 May; 58(5):504-10. PubMed ID: 9140559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence study of two limaprost alfadex 5 microg tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation).
    Nakade S; Komaba J; Ohno T; Kitagawa J; Furukawa K; Miyata Y
    Int J Clin Pharmacol Ther; 2008 Jan; 46(1):42-7. PubMed ID: 18218297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence of two oral ciprofloxacin tablets formulations.
    Cuadrado A; Gascón AR; Solinís MA; Ramírez E; Hernández RM; Knie U; Pedraz JL
    Int J Clin Pharmacol Ther; 2004 Jun; 42(6):336-41. PubMed ID: 15222727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid lowering effect of oxipurinol sodium in hyperuricemic patients - therapeutic equivalence to allopurinol.
    Walter-Sack I; de Vries JX; Ernst B; Frei M; Kolb S; Kosmowski J; Priebe U; Schroder HE; Slotty C; Voss A; Weber A; Wegscheider K
    J Rheumatol; 1996 Mar; 23(3):498-501. PubMed ID: 8832991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study.
    Ullah MA; Shams-Ud-Dowla ; Maruf AA; Azad MA; Shohag MH; Sultana R; Latif AH; Hasnat A
    Clin Ther; 2010 Jul; 32(7):1419-26. PubMed ID: 20678688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions.
    Elshafeey AH; Elsherbiny MA; Fathallah MM
    Clin Ther; 2009 Mar; 31(3):600-8. PubMed ID: 19393850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence evaluation of two different formulations of ciprofloxacin tablets in healthy volunteers.
    Hassan Y; Alfadly SO; Azmin MN; Peh KK; Tan TF; Noorizan AA; Ismail O
    Singapore Med J; 2007 Sep; 48(9):819-23. PubMed ID: 17728962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence study of generic tablet formulations containing ethinylestradiol and chlormadinone acetate in healthy female volunteers.
    Bonn M; Eydeler U; Barkworth M; Rovati LC
    Arzneimittelforschung; 2009; 59(12):651-8. PubMed ID: 20108652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers.
    Cho HY; Yoon H; Park GK; Lee YB
    Clin Ther; 2009 Nov; 31(11):2712-21. PubMed ID: 20110013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and comparative bioavailability of allopurinol formulations in healthy subjects.
    Helmy SA; El-Bedaiwy HM
    Clin Pharmacol Drug Dev; 2014 Sep; 3(5):353-7. PubMed ID: 27129007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.